Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 8 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Cardiff Oncology, Inc. | 1,330,676 | reported | 30 Jul 2025 | tx 24+1,536,915 |
| RESMED INC | 128,981 | reported | 08 May 2018 | tx 75+1,037,499−1,064,114 |
| Imunon, Inc. | 110,676 | reported | 19 Feb 2010 | tx 13+147,032 |
| Pacira BioSciences, Inc. | 22,127 | reported | 08 Mar 2024 | tx 59+364,572−291,559 |
| PEPLIN INC | 21,029 | reported | 03 Dec 2008 | tx 10+11,779 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 30 Jul 2025 | PURCHASE | Cardiff Oncology, Inc. | 275,000 | 2.45 USD | |
| 30 Jul 2025 | PURCHASE | Cardiff Oncology, Inc. | 15,000 | 2.45 USD | |
| 26 Jun 2025 | GRANT_AWARD | Cardiff Oncology, Inc. | 40,565 | 0.00 USD | deriv |
| 11 Dec 2024 | PURCHASE | Cardiff Oncology, Inc. | 11,500 | 2.60 USD | |
| 11 Dec 2024 | PURCHASE | Cardiff Oncology, Inc. | 350,115 | 2.60 USD | |
| 27 Jun 2024 | GRANT_AWARD | Cardiff Oncology, Inc. | 29,700 | 0.00 USD | deriv |
| 07 Mar 2024 | SALE | Pacira BioSciences, Inc. | 28,257 | 30.81 USD | |
| 06 Mar 2024 | SALE | Pacira BioSciences, Inc. | 1,066 | 29.67 USD | |
| 08 Mar 2024 | SALE | Pacira BioSciences, Inc. | 90,000 | 30.60 USD | |
| 19 Dec 2023 | PURCHASE | Cardiff Oncology, Inc. | 30,000 | 1.37 USD | |
| 10 Nov 2023 | PURCHASE | Cardiff Oncology, Inc. | 22,950 | 0.98 USD | first after silence |
| 15 Jun 2023 | GRANT_AWARD | Cardiff Oncology, Inc. | 27,700 | 0.00 USD | deriv |
| 14 Jun 2023 | GRANT_AWARD | Pacira BioSciences, Inc. | 1,775 | 0.00 USD | |
| 14 Jun 2023 | GRANT_AWARD | Pacira BioSciences, Inc. | 12,925 | 0.00 USD | deriv |
| 11 May 2023 | EXERCISE | Pacira BioSciences, Inc. | 7,000 | 29.90 USD | |
| 11 May 2023 | SALE | Pacira BioSciences, Inc. | 5,015 | 41.78 USD | |
| 11 May 2023 | EXERCISE | Pacira BioSciences, Inc. | 7,000 | 0.00 USD | deriv |
| 15 Sept 2022 | PURCHASE | Cardiff Oncology, Inc. | 150,000 | 1.71 USD | |
| 08 Jun 2022 | GRANT_AWARD | Pacira BioSciences, Inc. | 1,160 | 0.00 USD | |
| 08 Jun 2022 | GRANT_AWARD | Pacira BioSciences, Inc. | 8,225 | 0.00 USD | deriv |
| 09 Mar 2022 | GRANT_AWARD | Cardiff Oncology, Inc. | 26,800 | 0.00 USD | deriv |
| 03 Mar 2022 | EXERCISE | Pacira BioSciences, Inc. | 7,000 | 10.81 USD | |
| 03 Mar 2022 | EXERCISE | Pacira BioSciences, Inc. | 7,000 | 0.00 USD | deriv |
| 28 Feb 2022 | SALE | Pacira BioSciences, Inc. | 28,641 | 66.83 USD | |
| 01 Mar 2022 | EXERCISE | Pacira BioSciences, Inc. | 193 | 11.02 USD |
5 purchases reported after at least 12 months of silence — most recent on 10 Nov 2023.